Why Australia is a Go-To Destination for Clinical Trials episode artwork

EPISODE · Aug 28, 2019 · 11 MIN

Why Australia is a Go-To Destination for Clinical Trials

from The MTPConnect Podcast · host MTPConnect

The MTPConnect Podcast team recently caught up with Pfizer Ventures Managing Partner Dr Barbara Dalton to talk about Australia’s strengths as a destination to conduct clinical trials. Dr Dalton discusses what’s so attractive about Australia to international companies and we explore the potential to grow the export earning potential of our clinical trials ecosystem. 

The MTPConnect Podcast team recently caught up with Pfizer Ventures Managing Partner Dr Barbara Dalton to talk about Australia’s strengths as a destination to conduct clinical trials. Dr Dalton discusses what’s so attractive about Australia to international companies and we explore the potential to grow the export earning potential of our clinical trials ecosystem.

NOW PLAYING

Why Australia is a Go-To Destination for Clinical Trials

0:00 11:57

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The MTPConnect Podcast?

This episode is 11 minutes long.

When was this The MTPConnect Podcast episode published?

This episode was published on August 28, 2019.

What is this episode about?

The MTPConnect Podcast team recently caught up with Pfizer Ventures Managing Partner Dr Barbara Dalton to talk about Australia’s strengths as a destination to conduct clinical trials. Dr Dalton discusses what’s so attractive about Australia to...

Can I download this The MTPConnect Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!